Luis Labeaga

1.1k total citations
45 papers, 878 citations indexed

About

Luis Labeaga is a scholar working on Organic Chemistry, Molecular Biology and Physiology. According to data from OpenAlex, Luis Labeaga has authored 45 papers receiving a total of 878 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Organic Chemistry, 12 papers in Molecular Biology and 9 papers in Physiology. Recurrent topics in Luis Labeaga's work include Synthesis and Biological Evaluation (9 papers), Allergic Rhinitis and Sensitization (8 papers) and Asthma and respiratory diseases (8 papers). Luis Labeaga is often cited by papers focused on Synthesis and Biological Evaluation (9 papers), Allergic Rhinitis and Sensitization (8 papers) and Asthma and respiratory diseases (8 papers). Luis Labeaga collaborates with scholars based in Spain, Netherlands and Türkiye. Luis Labeaga's co-authors include Aurelio Orjales, Román Valiente, Erden Banoğlu, Francisco José da Silva Lédo, Antonio Entrena, Gökçen Eren, M. T. NUNEZ, Cristina Campo, Gabriele Costantino and Serdar Ünlü and has published in prestigious journals such as Journal of Medicinal Chemistry, Psychopharmacology and European Journal of Pharmacology.

In The Last Decade

Luis Labeaga

45 papers receiving 817 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luis Labeaga Spain 18 356 201 185 170 142 45 878
Aurelio Orjales Spain 15 289 0.8× 94 0.5× 99 0.5× 184 1.1× 47 0.3× 46 718
Todd A. Davis United States 14 200 0.6× 40 0.2× 147 0.8× 184 1.1× 26 0.2× 24 724
Jill M. Wetter United States 15 152 0.4× 49 0.2× 139 0.8× 316 1.9× 26 0.2× 22 646
Anthony F. Kreft United States 15 241 0.7× 21 0.1× 306 1.7× 255 1.5× 19 0.1× 35 911
Frank I. Carroll United States 10 104 0.3× 66 0.3× 98 0.5× 210 1.2× 44 0.3× 16 483
Giuseppina Morini Italy 17 184 0.5× 44 0.2× 181 1.0× 257 1.5× 8 0.1× 74 799
Sigurd Elz Germany 25 403 1.1× 54 0.3× 181 1.0× 1.3k 7.5× 11 0.1× 87 1.9k
Kuniaki Kawamura Japan 13 309 0.9× 35 0.2× 131 0.7× 411 2.4× 56 0.4× 27 824
Katsuichi Shuto Japan 12 128 0.4× 14 0.1× 119 0.6× 246 1.4× 17 0.1× 88 639
Laura Mennuni Italy 20 450 1.3× 22 0.1× 48 0.3× 449 2.6× 75 0.5× 50 1.0k

Countries citing papers authored by Luis Labeaga

Since Specialization
Citations

This map shows the geographic impact of Luis Labeaga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luis Labeaga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luis Labeaga more than expected).

Fields of papers citing papers by Luis Labeaga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luis Labeaga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luis Labeaga. The network helps show where Luis Labeaga may publish in the future.

Co-authorship network of co-authors of Luis Labeaga

This figure shows the co-authorship network connecting the top 25 collaborators of Luis Labeaga. A scholar is included among the top collaborators of Luis Labeaga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luis Labeaga. Luis Labeaga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gich, Ignasi, et al.. (2022). Lack of Clinical Relevance of Bilastine-Food Interaction in Healthy Volunteers: A Wheal and Flare Study. International Archives of Allergy and Immunology. 183(12). 1241–1250. 3 indexed citations
2.
Rodríguez, Mónica, Valvanera Vozmediano, Aintzane García‐Bea, et al.. (2020). Pharmacokinetics and safety of bilastine in children aged 6 to 11 years with allergic rhinoconjunctivitis or chronic urticaria. European Journal of Pediatrics. 179(5). 801–805. 12 indexed citations
3.
Sádaba, Belén, José Ramón Azanza Perea, Aintzane García‐Bea, et al.. (2019). Bioequivalence Evaluation of Three Pediatric Oral Formulations of Bilastine in Healthy Subjects: Results from a Randomized, Open Label, Crossover Study. European Journal of Drug Metabolism and Pharmacokinetics. 45(2). 265–272. 5 indexed citations
4.
Bosma, Reggie, et al.. (2018). The long duration of action of the second generation antihistamine bilastine coincides with its long residence time at the histamine H1 receptor. European Journal of Pharmacology. 838. 107–111. 26 indexed citations
5.
Vozmediano, Valvanera, John C. Lukas, Stephan Schmidt, et al.. (2018). Model-informed pediatric development applied to bilastine: Analysis of the clinical PK data and confirmation of the dose selected for the target population. European Journal of Pharmaceutical Sciences. 128. 180–192. 12 indexed citations
6.
7.
Jáuregui, I, Johannes G. Ramaekers, Kazuhiko Yanai, et al.. (2015). Bilastine: a new antihistamine with an optimal benefit-to-risk ratio for safety during driving. Expert Opinion on Drug Safety. 15(1). 89–98. 26 indexed citations
8.
Eren, Gökçen, Serdar Ünlü, Luis Labeaga, et al.. (2010). Synthesis, biological evaluation, and docking studies of novel heterocyclic diaryl compounds as selective COX-2 inhibitors. Bioorganic & Medicinal Chemistry. 18(17). 6367–6376. 89 indexed citations
9.
Orjales, Aurelio, et al.. (2007). Novel 2-(4-methylsulfonylphenyl)pyrimidine derivatives as highly potent and specific COX-2 inhibitors. Bioorganic & Medicinal Chemistry. 16(5). 2183–2199. 50 indexed citations
10.
Labeaga, Luis, et al.. (2006). Reversal of learned helplessness by selective serotonin reuptake inhibitors in rats is not dependent on 5-HT availability. Neuropharmacology. 52(3). 975–984. 33 indexed citations
11.
Labeaga, Luis, et al.. (2006). In Vivo Pharmacological Characterisation of Bilastine, a Potent??and Selective Histamine H1??Receptor Antagonist. Drugs in R&D. 7(4). 219–231. 56 indexed citations
12.
Olmo, Elena del, Álvaro Díaz, José Ángel Ruíz-Ortega, et al.. (2005). Preclinical pharmacology of F-98214-TA, a novel potent serotonin and norepinephrine uptake inhibitor with antidepressant and anxiolytic properties. Psychopharmacology. 182(3). 400–413. 16 indexed citations
13.
Labeaga, Luis, et al.. (2003). Synthesis and pharmacological characterization of a new benzoxazole derivative as a potent 5-HT3 receptor agonist. Bioorganic & Medicinal Chemistry. 11(13). 2709–2714. 19 indexed citations
14.
Orjales, Aurelio, et al.. (2002). New 3-benzisothiazolyl and 3-benzisoxazolylpiperazine derivatives with atypical antipsychotic binding profile. European Journal of Medicinal Chemistry. 37(9). 721–730. 14 indexed citations
15.
Iriepa, Isabel, et al.. (2002). Synthesis and pharmacology of isoquinuclidine derivatives as 5-HT3 ligands. Bioorganic & Medicinal Chemistry Letters. 12(2). 189–192. 19 indexed citations
16.
Orjales, Aurelio, et al.. (2000). Synthesis and 5-HT3 receptor affinity of new quinolinecarboxylic acid derivatives.. PubMed. 16(4). 271–9. 1 indexed citations
17.
Labeaga, Luis, et al.. (1998). Protective Effect of Hidrosmin Against Cisplatin‐induced Acute Nephrotoxicity in Rats. Pharmacy and Pharmacology Communications. 4(9). 465–467. 6 indexed citations
18.
Orjales, Aurelio, et al.. (1995). New (2-Methoxyphenyl)piperazine Derivatives as 5-HT1A Receptor Ligands with Reduced .alpha.1-Adrenergic Activity. Synthesis and Structure-Affinity Relationships. Journal of Medicinal Chemistry. 38(8). 1273–1277. 47 indexed citations
19.
Fernández, María‐José, Enrique J. Galvez, Aurelio Orjales, et al.. (1995). Structural, conformational, theoretical and pharmacological study of some amides derived from 3,7-dimethyl-9-[(N-substituted)-4-chlorobenzamido]3,7-diazabicyclo[3.3.1]nonane-9-carboxamide. Journal of Molecular Structure. 351. 137–146. 2 indexed citations
20.
Fernández, María‐José, Enrique J. Galvez, Aurelio Orjales, et al.. (1992). Synthesis, and structural, conformational and pharmacological studies of new fentanyl derivatives of the norgranatane system. Journal of the Chemical Society Perkin Transactions 2. 687–695. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aurelio Orjales Breakdown of academic impact, for papers by Todd A. Davis Breakdown of academic impact, for papers by Jill M. Wetter Breakdown of academic impact, for papers by Anthony F. Kreft Breakdown of academic impact, for papers by Frank I. Carroll Breakdown of academic impact, for papers by Giuseppina Morini Breakdown of academic impact, for papers by Sigurd Elz Breakdown of academic impact, for papers by Kuniaki Kawamura Breakdown of academic impact, for papers by Katsuichi Shuto Breakdown of academic impact, for papers by Laura Mennuni
Rankless by CCL
2026